OrPha Swiss GmbH - Ambrisentan OrPha 10 mg, Filmtabletten | | 67500 | | 02 | | Ambrisentan OrPha 10 mg | | Filmtabletten | | C02KX02 | | Ambrisentan | | 16.12.2022 | | |
| Composition | ambrisentanum 10 mg, cellulosum microcristallinum, lactosum monohydricum 95.0 mg, carmellosum natricum conexum corresp. natrium 0.35 mg, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, E 129 0.405 mg, lecithinum ex soja, E 171, pro compresso obducto. | Packungsbestandteile | | Coated tablets | | | | BAG: Active Agent | Dose |
---|
| 10 mg |
| | Inactive agents | Dose | additional_information |
---|
| | | | | | | 0.405 mg | color. | | | color. | Lactose Monohydrate | 95 mg | | | | | Macrogol | 3350 | | | | | | | Überzug | | | | Talcum | | |
| |
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
---|
002 | 30 | 990.57 | 1093.70 | B | SL | No |
|
|